Controlling protein function using small molecules
Regulated Protein Degradation
This study is exploring new ways to control how proteins work in our cells without changing our genes, which could help scientists better manage important substances in the body, like hormones and immune signals, using safe, approved medications.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10650884 on NIH RePORTER |
What this research studies
This research focuses on developing innovative methods to regulate protein function directly at the protein level, rather than through genetic manipulation. By engineering small protein domains that can be rapidly degraded, researchers aim to control the levels of specific proteins in mammalian cells. The project includes creating new destabilizing domains that respond to FDA-approved drugs and developing techniques to regulate the secretion of important cytokines and hormones. This approach could lead to the creation of genetically encoded biosensors for monitoring cellular processes.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with conditions that could benefit from targeted protein regulation, such as those requiring specific cytokine or hormone therapies.
Not a fit: Patients with conditions unrelated to protein regulation or those who do not require targeted therapeutic interventions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more precise and effective treatments for various diseases by enabling targeted control of protein functions.
How similar studies have performed: Other research has shown promise in using similar approaches for protein regulation, indicating potential for success in this novel application.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Wandless, Thomas James — Stanford University
- Study coordinator: Wandless, Thomas James
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.